All News about Reata Pharma
![](https://mms.businesswire.com/media/20230306005321/en/1133860/5/REATA_PHARM_Normal_LOGO.jpg)
![](https://mms.businesswire.com/media/20230303005418/en/1510725/22/Latest_KSF_SEC.jpg)
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/723127/parabola.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/02/stock_whisper_index_logo_6_copy.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/stock_chart_higher_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image44.jpg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/february/mmc/new-mmc-march1.jpg?sfvrsn=2588ab06_2)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/01/reta_mark_light__93173df3a0ae1a0e60349021e2c76cd7.png?width=1200&height=800&fit=crop)
Why Reata Pharma Shares Are Skyrocketing Today
March 01, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-DrugsPills-04-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image_2.jpg?width=1200&height=800&fit=crop)
![](https://spotlightgrowth.com/wp-content/uploads/2023/03/Reata-Pharmaceuticals-NASDAQ-RETA-FDA-Approval-SKYCLARYS-Friedreichs-Ataxia-Spotlight-Growth.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image_6_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image16_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image-reata_pharmaceuticals.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/722915/biotech-scientist-microscope-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2023/01/nvax1600.png)
![](https://investorplace.com/wp-content/uploads/2019/12/eye-1600.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image12.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/07/medicine-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://mms.businesswire.com/media/20230228006450/en/1133860/5/REATA_PHARM_Normal_LOGO.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3597.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/27/image27.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/01/Stock-Drugs-024-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.